文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

HLH treatment: smarter, not harder.

作者信息

Henderson Lauren A, Degar Barbara A

机构信息

Boston Children's Hospital; and.

Dana-Farber Cancer Institute.

出版信息

Blood. 2022 Jun 16;139(24):3453-3455. doi: 10.1182/blood.2022016421.

DOI:10.1182/blood.2022016421
PMID:35708727
Abstract
摘要

相似文献

[1]
HLH treatment: smarter, not harder.

Blood. 2022-6-16

[2]
A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis.

Blood. 2022-6-16

[3]
Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale.

J Oncol Pharm Pract. 2020-6

[4]
Hemophagocytic lymphohistiocytosis (HLH): a review of literature.

Med Oncol. 2013-10-9

[5]
Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.

J Oncol Pharm Pract. 2022-1

[6]
Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children.

World J Pediatr. 2020-8

[7]
Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report.

Medicine (Baltimore). 2021-3-19

[8]
Hemophagocytic Lymphohistiocytosis in Adults.

Hematol Oncol Clin North Am. 2015-10

[9]
Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.

Blood Rev. 2016-11

[10]
Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis.

Pediatr Rheumatol Online J. 2021-4-1

引用本文的文献

[1]
Barriers and solutions for CAR-T therapy in solid tumors.

Cancer Gene Ther. 2025-6-27

[2]
Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma.

J Hematol. 2025-6

[3]
Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity.

Cancers (Basel). 2023-10-26

[4]
Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review.

J Clin Med. 2023-8-25

[5]
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Transplant Cell Ther. 2023-7

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索